Prezcobix, New Once-Daily HIV Drug, Approved by FDA

By Warren Tong

From TheBodyPRO

January 30, 2015

On Jan. 29, Prezcobix, a once-daily combination drug, was approved by the U.S. Food and Drug Administration (FDA), for the treatment of HIV in adults.

The new drug contains 800 mg of the protease inhibitor darunavir (Prezista) and 150 mg of the pharmacokinetic booster cobicistat (Tybost). Prezcobix is recommended to be taken once a day with food, and in conjunction with other antiretroviral agents.

(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Beforeadding your comment, please read TheBody.com's Comment Policy.)

TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.